Use of the bivalent respiratory syncytial virus (RSV) vaccine (Abrysvo™, Pfizer) during pregnancy for the prevention of RSV–associated lower respiratory tract disease in Infants

Abstract

Recommendation of the use of the bivalent RSV vaccine during pregnancy for the prevention of RSV-associated lower respiratory tract disease in Infants.

Recommendation
Africa
South Africa
pregnant women
RSV (Respiratory syncytial virus)